Medibio Limited (MEB:ASX)

0.8¢

right-arrow Created with Sketch. 0 (0%)
MCAP $14.33M
Last trade 10.04am 07/05/2021 20mins delayed

Latest Announcements

04/05/2021 Price SensitivePSMEBMedibio Limited
30/04/2021 Price SensitivePSMEBMedibio Limited
29/04/2021 Price SensitivePSMEBMedibio Limited
22/04/2021 Price SensitivePSMEBMedibio Limited
15/04/2021MEBMedibio Limited
285
MCap
08/04/2021MEBMedibio Limited
420
MCap
08/04/2021MEBMedibio Limited
98
MCap
08/04/2021MEBMedibio Limited
91
MCap

Company Overview

Medibio Limited is an Australia-based company engaged in conducting research and development and early-stage commercialization of a diagnostic technology for mental health, which is based on circadian heart rate (CHR) data. The Company completed the development and testing of its Corporate Stress Product, a cloud-based product, including real-time electrocardiogram (ECG) Data Streaming and Algorithm Processing with results back to the Company's application in real time. The Company offers a Corporate Wellness Partner Program. The Company is also engaged in the development of a sleep staging algorithm, which using ECG data only, can distinguish between the stages of sleep. The Company's subsidiaries include Medibio Limited-USA, Invatec Health Pty Ltd and Annapanna Pty Ltd, which are engaged in CHR diagnostic development.

MEB in the news

Search Previous Announcements